Patients with musculoskeletal truma injury. Other disorders of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention 1: First intervention group: The group receiving IV morphine at a dose of 0.1
mg/kg of body weight. Intervention 2: Second intervention:The group receiving IV ketamine at a dose of
0.2
Treatment - Drugs
First intervention group: The group receiving IV morphine at a dose of 0.1
mg/kg of body weight
Second intervention:The group receiving IV ketamine at a dose of
0.2 mg/kg of body weight
Sponsors
Vice Chancellor for research of Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients in the age range of 18-70 Years, Severe acute musculoskeletal pain between 6-10 VAS Exclusion criteria included : patient refusal addiction SBP<90 GCS<90 presence of cardiac, pulmonary , renal, psychiatric disease Pregnancy or breast feeding allergy to ketamine or morphine, require to CNC block inability to underestand the vas concepts
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreasing pain severity. Timepoint: 0,30,60 minute after intervention. Method of measurement: Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Itchy. Timepoint: 0,30 60 minet after injection. Method of measurement: Researcher observation or patient discribe. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Fattahi
Iran University of Medical Sciences
Outcome results
None listed